A clinical trial with CNS10-NPC-GDNF transplanted unilaterally into the lumbar spinal cord of 18 ALS (Amyotrophic Lateral Sclerosis) participants in a Phase I/IIa study showed safety during the first year of examination. The gene discussed is GDNF; the disease is amyotrophic lateral sclerosis.